EX-99.2 4 y93461exv99w2.txt SUPPLEMENTAL INFORMATION Exhibit 99.2 MERCK & CO., INC. OTHER FINANCIAL DISCLOSURES FOURTH QUARTER 2003 NET PRODUCT SALES DETAIL (millions of dollars)
4Q `03 vs. 4Q `02 ------------------------------------------------------------- TOTAL TOTAL U.S. U.S. FOREIGN FOREIGN PRODUCT % CHG $ MM % CHG $ MM % CHG $ MM ------- ----- ---- ----- ---- ------- ------- AGGRASTAT -40% $ 22 -94% $ 1 12% 21 ARCOXIA * 23 -- -- * 23 CANCIDAS * 90 * 55 * 35 COZAAR / HYZAAR 1% 690 -20% 237 17% 453 CRIXIVAN / STOCRIN -20% 62 -54% 14 1% 48 EMEND * 8 * 8 * 0 FOSAMAX -6% 650 -30% 324 42% 326 INVANZ 59% 12 28% 8 * 4 MAXALT 7% 94 -1% 65 31% 29 PRIMAXIN -15% 149 -61% 26 15% 123 PRINIVIL / PRINZIDE * 16 * 4 -28% 12 PROPECIA 7% 64 0% 27 13% 37 PROSCAR 2% 168 -10% 76 16% 92 SINGULAIR 0% 507 -15% 328 47% 180 TIMOPTIC / TIMOPTIC XE 0% 43 -24% 4 3% 39 TRUSOPT / COSOPT 16% 137 7% 56 23% 80 VASOTEC / VASERETIC -2% 209 47% (1) -2% 211 VIOXX 95% 731 * 436 28% 295 ZOCOR -30% 1,214 -29% 762 -31% 452 HEPATITIS VACCINES -5% 53 -6% 44 -4% 9 VIRAL VACCINES -3% 122 -7% 111 69% 12 OTHER VACCINES 13% 92 12% 78 18% 14
* > 100% TOTAL SALES: VOLUME, PRICE, EXCHANGE
4Q `03 % CHG. VOL PX FX ------ ------ --- -- -- TOTAL PHARMACEUTICAL SALES $5,627 -7% -13 1 5 ------ ---- --- -- -- U.S. ($ MM) 3,151 -14% -16 2 0 Foreign ($ MM) 2,476 3% -8 -1 12
Exhibit 99.2 MERCK & CO., INC. OTHER FINANCIAL DISCLOSURES FULL YEAR 2003 NET PRODUCT SALES DETAIL (millions of dollars)
DECEMBER YTD `03 vs. DECEMBER YTD `02 --------------------------------------------------------------------------------------- TOTAL TOTAL U.S. U.S. FOREIGN FOREIGN PRODUCT % CHG $ MM % CHG $ MM % CHG $ MM ------- ----- ---- ----- ---- -------- ------- AGGRASTAT -16% $ 96 -67% $ 18 27% 78 ARCOXIA * 70 - - * 70 CANCIDAS * 276 * 166 * 110 COZAAR / HYZAAR 14% 2,486 -2% 899 26% 1,587 CRIXIVAN / STOCRIN -1% 291 -14% 92 6% 199 EMEND * 27 * 26 * 1 FOSAMAX 19% 2,677 2% 1,563 56% 1,114 INVANZ * 37 * 28 * 9 MAXALT 13% 324 5% 224 34% 100 PRIMAXIN 7% 629 -3% 179 12% 450 PRINIVIL / PRINZIDE -75% 116 -85% 61 -19% 55 PROPECIA 12% 239 13% 111 12% 128 PROSCAR 11% 606 2% 272 19% 334 SINGULAIR 35% 2,009 30% 1,399 48% 611 TIMOPTIC / TIMOPTIC XE -4% 160 -34% 16 1% 144 TRUSOPT / COSOPT 14% 484 8% 202 19% 283 VASOTEC / VASERETIC -4% 764 * (12) -2% 775 VIOXX 2% 2,549 -9% 1,535 24% 1,014 ZOCOR -8% 5,011 -1% 3,144 -17% 1,868 HEPATITIS VACCINES 6% 241 6% 204 8% 38 VIRAL VACCINES -4% 534 -7% 494 90% 40 OTHER VACCINES 14% 281 11% 229 28% 52
* > 100% TOTAL SALES: VOLUME, PRICE, EXCHANGE
YTD `03 % CHG. VOL PX FX TOTAL PHARMACEUTICAL SALES $22,486 5% 0 1 4 -------- --- -- -- -- U.S. ($ MM) 13,321 1% -1 2 0 Foreign ($ MM) 9,165 11% 1 -1 11
Exhibit 99.2 MERCK & CO., INC. OTHER FINANCIAL DISCLOSURES FOURTH QUARTER 2003 OTHER (INCOME)/EXPENSE, NET FROM CONTINUING OPERATIONS ( millions of dollars)
4Q `03 4Q `02 YTD 2003 YTD 2002 ------ ------ -------- -------- INTEREST INCOME $(72.2) $(107.3) $(308.7) $(415.1) INTEREST EXPENSE 80.0 98.1 350.9 390.8 EXCHANGE (GAINS)/LOSSES (3.3) (18.7) (28.4) (7.8) MINORITY INTERESTS 37.2 44.5 168.7 214.2 AMORTIZATION OF INTANGIBLES 36.5 30.1 140.8 120.0 Other, net (134.7) 23.6 (404.9) (99.5) ------ ---- ------ ----- TOTAL $(56.5) $ 70.3 $ (81.6) $ 202.6 ------ ---- ------ -----
JOINT VENTURE SALES DETAIL (millions of dollars) All sales reported here are end-market JV sales, presented on a "NET" basis.
MERIAL 4Q `03 4Q `02 YTD 2003 YTD 2002 ------ ------ ------ -------- -------- IVOMEC, HEARTGARD, other avermectins $123 $112 $ 475 $ 462 FRONTLINE 91 77 576 486 Biologicals 117 102 422 376 Other Animal Health 59 47 211 181 Poultry Genetics 41 40 154 157 ---- ---- ------ ------ TOTAL MERIAL SALES $431 $378 $1,838 $1,662 ---- ---- ------ ------
AVENTIS PASTEUR-MSD 4Q `03 4Q `02 YTD 2003 YTD 2002 ------------------- ------ ------ -------- -------- HEPATITIS VACCINES $ 18 $ 20 $ 74 $ 69 VIRAL VACCINES 11 8 51 35 Other Vaccines 140 116 543 442 ---- ---- ---- ---- TOTAL AP-MSD SALES $170 $144 $669 $546 ---- ---- ---- ----
MERCK / SCHERING-PLOUGH COLLABORATION 4Q `03 4Q `02 YTD 2003 YTD 2002 ------------------------------------- ------ ------ -------- -------- Zetia (Worldwide) $164 $25 $469 $25 TOTAL $164 $25 $469 $25